Key result
High circulating concentrations of NT-proBNP were associated with a higher risk of incident heart failure overall (HR 2.56), though the association was linear in non-obese and U-shaped in obese adults.
Why the study?
Does NT-proBNP concentration predict incident heart failure differently based on obesity status in middle-aged adults?
Cohort (n=1,360)
No
Does NT-proBNP concentration predict incident heart failure differently based on obesity status in middle-aged adults?
While NT-proBNP is positively associated with incident heart failure overall, obese individuals exhibit a U-shaped risk curve where both low and high NT-proBNP levels predict increased heart failure risk.
Answers are grounded in this paper and cite their sources.
NT-proBNP may require obesity-adjusted HF risk interpretation; leaves open prospective validation of U-shaped associations.
BACKGROUND: Both high concentrations of N-terminal pro-brain natriuretic peptide (NT-proBNP) and obesity are related to higher heart failure risk. However, inverse relationships between NT-proBNP and obesity have been reported. Therefore, it was investigated whether the association between NT-proBNP and the risk of heart failure differed according to obesity status. METHODS: A case-cohort study was conducted within the European Prospective Investigation into Cancer and Nutrition (EPIC)-Potsdam, comprising a random sub-cohort (non-cases = 1,150, cases = 13, mean age: 50.5±9.0 years) and heart failure cases outside the sub-cohort (n = 197). Weighted Cox proportional hazards regression was used to examine the association between NT-proBNP and heart failure risk during a mean follow-up time of 8 years. Stratified analyses were performed according to obesity status as defined by body mass index (<30 kg/m2 versus ≥30 kg/m2). RESULTS: Overall, NT-proBNP was associated with higher risk of heart failure after multivariable adjustment (hazard ratio (HR) and 95% confidence interval (CI): 2.56 (1.49-4.41) for the top versus bottom tertile of NT-proBNP, ptrend:<0.01). In stratified analyses, the shape of association was linear in non-obese and U-shaped in obese participants: HRs (95%CI) from the first to the third tertile of NT-proBNP for non-obese: reference, 1.72 (0.85-3.49), 2.72 (1.42-5.22), and for obese: 3.29 (1.04-10.40), reference, 3.74 (1.52-9.21). CONCLUSIONS: Although high circulating concentrations of NT-proBNP were positively associated with incident heart failure in the entire sample, the association differed according to obesity status. In obese, an increased risk of heart failure was also observed in those with low NT-proBNP concentrations. If confirmed, this observation warrants further investigation to understand underlying pathophysiological mechanisms.
No takes yet. Share an insight, caveat, or question.
Wirth et al. (2014) conducted a cohort in Heart Failure (n=1,360). N-Terminal Pro-Brain Natriuretic Peptide (NT-proBNP) vs. Bottom tertile of NT-proBNP was evaluated on Incident heart failure (HR 2.56, 95% CI 1.49-4.41, p=<0.01). High circulating concentrations of NT-proBNP were associated with a higher risk of incident heart failure overall (HR 2.56), though the association was linear in non-obese and U-shaped in obese adults.
Synapse has enriched 10 related papers. Consider them for comparative context: